Crohn Disease (CD): Clinical Trials

101 trials for Crohn Disease (CD), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

54 recruiting, 20 not yet recruiting, 15 completed, 7 enrolling by invitation. 33 Not applicable, 11 Phase 2, 7 Phase 1, 6 Phase 4, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable33Recruiting 20, Completed 6, Not yet recruiting 6, Enrolling by invitation 1
Phase 211Recruiting 7, Not yet recruiting 2, Enrolling by invitation 1, Unknown 1
Phase 17Not yet recruiting 3, Recruiting 3, Active not recruiting 1
Phase 46Recruiting 4, Enrolling by invitation 1, Not yet recruiting 1
Early Phase 11Completed 1
Phase 31Enrolling by invitation 1

Follow Crohn Disease (CD): new trials by email Literature Review of Crohn Disease (CD) trials Research Report on Crohn Disease (CD)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Adapted Physical Activity for Persistent Fatigue in Patients With Inflammatory Bowel Disease in Remission
Adapted Physical Activity, Usual Care - Inflammatory Bowel Diseases (IBD), Fatigue
Not applicableNot yet recruitingUniversity Hospital, Grenoble1202027-06-012026-09-11
R-3750 in Patients With Crohn's Disease
R-3750, Placebo - Crohn Disease (CD)
Phase 1Not yet recruitingRise Therapeutics LLC402026-11-012026-08-28
MENA/Levant Epidemiological, Registry of Immunological & Clinical Traits (MERIT)
Antiphospholipid (aPL)-Positive, Rheumatic Arthritis
Not yet recruitingAxiom Bioregistry50002026-10-182026-10-23
Ex Vivo Comparison Of Combination Versus Single Therapeutic Pathway Inhibition In Human Intestinal Mucosa From Patients With Inflammatory Bowel Disease
Collection of 8 additional intestinal mucosal biopsies during standard-of-care endoscopy for subsequent ex vivo testing, Collection of an additional 2 mL blood sample - Ulcerative Colitis (UC), IBD (Inflammatory Bowel Disease)
Not applicableNot yet recruitingPhoenixLAB srls302026-10-012026-09-17
Virtual hIStology of Crohn's Disease Ex-vivo Resected Anatomical Lesions
Crohn Disease (CD)
RecruitingCentral Hospital, Nancy, France602026-09-252026-10-21
Characterization of Colorectal Dysplasic Lesions and Stratification of Their Evolving Risk in Inflammatory Bowel Disease Patients: a Prospective, Observational and Multicenter Study
Crohn Disease (CD), Colitis Ulcerative
Not yet recruitingGroupe d'Etude Therapeutique des Affections Inflammatoires Digestives8002026-09-152026-07-22
INSIGHT-IBD Pragmatic Study
Mirikizumab, Anti-TNF agents, anti-integrin antibodies - Ulcerative Colitis (UC), Crohn Disease (CD)
Phase 4Enrolling by invitationSpecialty Networks Research.4002026-08-122026-10-29
Prospective Evaluation of Flare Detection in IBD With Digital Biomarkers: Bring Your Own Device Study
Wearing their own wearable device. - Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC)
RecruitingMaastricht University Medical Center6002026-08-042026-10-13
Impact of Ultra-Processed Food Reduction on Remission Duration in Pediatric Crohn's Disease
Ultra-Processed Food Reduction Counseling, Standard Dietary Counseling - Crohn Disease (CD)
Not applicableRecruitingUniversity Hospital, Motol1242026-08-012026-10-20
HB-adMSCs for the Treatment of Crohn's Disease
HB-adMSCs - Hope Biosciences Adipose Derived Mesenchymal Stem Cells, 0.9% sodium chloride - Crohn Disease (CD)
Phase 2RecruitingHope Biosciences Research Foundation462026-07-142026-08-06
Optimal Care With Guselkumab in Crohn's Disease / OPTIM Study A Prospective Open Label Interventional, Multicenter Study
Guselkumab - Crohn Disease (CD), Intensification
Phase 4RecruitingGroupe d'Etude Therapeutique des Affections Inflammatoires Digestives2102026-06-182026-06-30
VR Therapies for IBD
Distraction VR, VR/AI CBT - Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC)
Not applicableNot yet recruitingBrennan Spiegel762026-06-012026-05-15
DB-3Q for the Treatment of Medically Refractory Crohn's Disease
DB-3Q, Placebo - Crohn Disease (CD)
Phase 2RecruitingDirect Biologics, LLC362026-06-012026-09-01
Efficacy of MIrikizumab to Achieve Transmural Healing in patiENTs With Crohn's Disease
Mirikizumab - IV, Mirikizumab - SC - Crohn Disease (CD)
Phase 4RecruitingGroupe d'Etude Therapeutique des Affections Inflammatoires Digestives752026-05-112026-05-26
Clostridium Butyricum in Stenosing Crohn's Disease
Clostridum Butyricum Capsule, Trehalose - Crohn Disease (CD)
Phase 1 / Phase 2RecruitingSan Giovanni Addolorata Hospital402026-05-082026-09-04
Leucine-rich α2-glycoprotein Correlation With Clinical, Endoscopic and Histological Disease Activity of IBD in a EuRopean Context
Leucine-rich α2-glycoprotein - Crohn Disease (CD), Ulcerative Colitis (UC)
RecruitingImelda GI Clinical Research Center1002026-05-012026-06-02
Qualitative Exploration of Key Symptoms of Stricturing Crohn's Disease: Toward the Development of a Clinical Assessment Score.
Semi-structured interview - Crohn Disease (CD)
Not yet recruitingUniversity Hospital, Grenoble152026-05-012026-05-20
Concordance Between Inflammatory Activity Assessed by Enteric MRI With and Without Intestinal Distension Product in Patients With Ileal Crohn's Disease.
MRI - Crohn Disease (CD)
Not applicableRecruitingUniversity Hospital, Clermont-Ferrand602026-04-222026-07-30
Combining Nutritional Therapy and Anti-TNFα Treatment in Pediatric Patients With Crohn's Disease
IFX + mCDED - Crohn Disease (CD), IBD (Inflammatory Bowel Disease)
Not applicableRecruitingUniversity of British Columbia1402026-04-222026-05-01
Regenerative Endoscopy in Refractory Perianal Crohn's Disease
Autologous Mechanical Tissue Stromal Vascular Fraction (tSVF) Injection - Crohn Disease (CD), Perianal Crohns Disease
Not applicableRecruitingAsian Institute of Gastroenterology, India502026-04-202026-06-17

Showing 20 of 101. Sign in to see all of them.

Narrower conditions

Crohn Disease (101)  ·  Colitis, Ulcerative (51)  ·  Inflammatory Bowel Diseases (40)  ·  Irritable Bowel Syndrome (4)  ·  Arthritis, Rheumatoid (3)  ·  Psoriasis (3)  ·  Anxiety Disorders (2)  ·  Arthritis, Psoriatic (2)  ·  Autism Spectrum Disorder (2)  ·  Autoimmune Diseases (2)  ·  Celiac Disease (2)  ·  Colonic Neoplasms (2)  ·  Colorectal Neoplasms (2)  ·  Disease (2)  ·  Fatigue (2)

Broader conditions

Digestive System Diseases (101)  ·  Gastroenteritis (101)  ·  Gastrointestinal Diseases (101)  ·  Intestinal Diseases (101)  ·  Inflammatory Bowel Diseases (61)  ·  Colonic Diseases (52)  ·  Colitis (51)  ·  Pathological Conditions, Signs and Symptoms (16)  ·  Pathologic Processes (10)  ·  Arthritis (7)  ·  Joint Diseases (7)  ·  Musculoskeletal Diseases (7)  ·  Signs and Symptoms (6)  ·  Behavior (5)  ·  Connective Tissue Diseases (5)

Interventions

Infliximab (5)  ·  Adalimumab (3)  ·  Ustekinumab (3)  ·  Cholecalciferol (2)  ·  Dietary Fiber (2)  ·  guselkumab (2)  ·  mirikizumab (2)  ·  trichlorosucrose (2)  ·  vedolizumab (2)  ·  Blood Specimen Collection (1)  ·  Budesonide (1)  ·  Capsule Endoscopy (1)  ·  Celecoxib (1)  ·  Certolizumab Pegol (1)  ·  Diet (1)

Sponsors

Sixth Affiliated Hospital, Sun Yat-sen University (5)  ·  University Hospital, Clermont-Ferrand (4)  ·  Asian Institute of Gastroenterology, India (3)  ·  Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives (3)  ·  Shmuel Kivity, MD (3)  ·  University of Southern Denmark (3)  ·  GLSMED Learning Health S.A. (2)  ·  Imelda GI Clinical Research Center (2)  ·  Pontificia Universidad Catolica de Chile (2)  ·  TIDHI Innovation Inc. (2)  ·  University Hospital, Grenoble (2)  ·  University Medical Center Groningen (2)  ·  Alimentiv Inc. (1)  ·  American Laboratory Products Company (1)  ·  Ana Maldonado-Contreras (1)

Countries

United States (16)  ·  France (14)  ·  China (10)  ·  Italy (9)  ·  Canada (7)  ·  Netherlands (6)  ·  Belgium (4)  ·  Denmark (3)  ·  Germany (3)  ·  India (3)  ·  Israel (3)  ·  Sweden (3)  ·  Chile (2)  ·  Poland (2)  ·  Portugal (2)

Top investigators

Anthony Buisson (2)  ·  Vibeke Andersen, Prof (2)  ·  Abigail Raffner, RD PhD (1)  ·  Abigal Raffner, PhD, RD (1)  ·  Ana Maldonado-Contreras, PhD (1)  ·  Andres Yarur, MD (1)  ·  Ayal Hirsch, MD (1)  ·  Barry Salky, MD (1)  ·  Brennan Spiegel, MD, MSHS (1)  ·  Calum Moulton (1)  ·  Casey Chapman, MD (1)

Results publications

PMID 19248087, PMID 20498207, PMID 21622969, PMID 21885496, PMID 13592638, PMID 19528959, PMID 20203603, PMID 22186710, PMID 22459541, PMID 23160295, PMID 23625981, PMID 23956246, PMID 23964932, PMID 24798552, PMID 24845387, PMID 25417763, PMID 26017497, PMID 27125522, PMID 27329806, PMID 27383983, PMID 28393285, PMID 28405472, PMID 29065931, PMID 29373733, PMID 29439003, PMID 30809016, PMID 30928934, PMID 31126334, PMID 31362994, PMID 32433595, PMID 35483736, PMID 36313095, PMID 38604541, PMID 38658485, PMID 38754881, PMID 38973149, PMID 39922705, PMID 40545788, PMID 41286498

NIH funding

2025 (3), R01DK144719 (1)